跳至主要内容
临床试验/ISRCTN70120536
ISRCTN70120536已完成未知

Characterisation of the peptide and cellular constituents of cerebrospinal fluid implicated in the chronicity of neuropathic pain in vivo and its response to treatment with amitriptyline and neuromodulation

St James's Hospital / Trinity College Dublin0 个研究点目标入组 20 人开始时间: 2017年9月12日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
20

研究概览

简要总结

2021 Results article in https://doi.org/10.1016/j.bbih.2020.100184 (added 11/10/2023)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Amitriptyline study:
  • 1. Patients aged 20 – 65 years with lumbar radicular pain
  • 2. Clinical and radiological evidence of one nerve root and/or dermatome affected
  • Neuromodulation study:
  • 1. Patients aged 20 – 65 years with FBSS or CRPS who have been implanted with a spinal cord stimulator

排除标准

  • Amitriptyline study:
  • 1. Patient refusal
  • 2. Anticoagulant medication
  • 3. Infection
  • 4. Pregnancy
  • 5. Breastfeeding
  • 6. Corticosteroid therapy
  • 8. Psychiatric history
  • 9. History of ischaemic heart disease
  • 10. Arrhythmia
  • 11. Heart block
  • 12. Cerebral impairment
  • 13. Current anti-neuropathic medication
  • 14. Biologic medication
  • Neuromodulation study:
  • 1. Patient refusal
  • 2. Anticoagulant medication
  • 3. Infection
  • 4. Pregnancy
  • 5. Breastfeeding
  • 6. Corticosteroid therapy
  • 8. Psychiatric history
  • 9. Cerebral impairment
  • 10. Biologic medication

研究者

发起方
St James's Hospital / Trinity College Dublin

相似试验